May 10, 2023 / 08:40PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Welcome to Bank of America's 2023 Healthcare Conference, coming to you live from the Encore here in Las Vegas. I'm Derik De Bruin, the senior life sciences and diagnostics tools analyst. And our next company to -- we're going to chat with is Bio-Techne. And with us is Chuck Kummeth, CEO.
Chuck, welcome. Thanks for coming to Vegas.
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Thanks for inviting us, as always.
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
I appreciate you putting up with us and coming down. So you just reported earnings last week. You want to kick off with that and sort of do a recap?
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Yes, sure, if I can get my voice back. I told my team we got to stop doing this afternoon meetings. Running out of steam and voice.
But the quarter
Bio-Techne Corp at Bank of America Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot